SCPH

Scpharmaceuticals INC

+$89.5M

Net Activity

Institutions Holding

114

Popularity Rank

#4002

Avg Weight

0.07%

Total Value

$237.9M

Ownership Trend

114 institutions currently hold SCPH, with 74 net buyers and 56 net sellers this quarter.

Institutional Moves

Institutional Moves (Q3 2025)

Neutral

Based on recent trading activity

Net Selling Institutions

56

Net Buying Institutions

74

Key Holders

View all 114 holding institutions

Quarterly Activity

Recent Activity

+$164.0M

Total Buy Value

$52.4M

Total Sell Value

New buy48
Trim33
Add26
Sold out23

74

Net Buyers

56

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding SCPHARMACEUTICALS INC (SCPH)?
Major stakeholders currently include Orbimed Advisors LLC ($34.4M), Rubric Capital Management LP ($28.9M), Weiss Asset Management LP ($16.3M). Based on the latest 13F filings, there are a total of 114 tracked investment funds and institutions maintaining positions in SCPH.
What is the overall institutional sentiment toward SCPH recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $89.5M, driven by 74 managers accumulating shares while 56 reduced their exposure.
Which institutions have been selling or reducing their SCPH positions?
In the latest period, 33 funds trimmed their holdings, and 23 managers completely exited their positions. The aggregate reported sell value was $52.4M.
Are there any notable investors adding SCPH to their portfolios?
Yes, buying activity remains notable. 48 institutions opened new positions in {ticker}, and 26 existing holders added to their shares. The total reported buy value for the quarter amounted to $164.0M.

Related Stocks